A comparison of Sars-Cov-2 vaccine platforms: the CoviCompare project

被引：10

作者：

Molino, Diana ^{[1
]}

Durier, Christine ^{[2
]}

Radenne, Anne ^{[3
]}

Desaint, Corinne ^{[2
]}

Ropers, Jacques ^{[3
]}

Courcier, Soizic ^{[1
]}

Vieillard, Louis Victorien ^{[1
]}

Rekacewicz, Claire ^{[1
]}

Parfait, Beatrice ^{[4
]}

Appay, Victor ^{[5
]}

Batteux, Frederic ^{[6
]}

Barillot, Emmanuel ^{[7
]}

Cogne, Michel ^{[8
,9
]}

Combadiere, Behazine ^{[10
]}

Eberhardt, Christiane S. ^{[11
,12
]}

Gorochov, Guy ^{[13
]}

Hupe, Philippe ^{[7
,14
]}

Ninove, Laetitia ^{[15
]}

Paul, Stephane ^{[16
]}

Pellegrin, Isabelle ^{[5
]}

van der Werf, Sylvie ^{[17
]}

Lefebvre, Maeva ^{[18
]}

Botelho-Nevers, Elisabeth ^{[19
]}

Ortega-Perez, Inmaculada ^{[20
]}

Jaspard, Marie ^{[21
,22
]}

Sow, Samba ^{[23
]}

Lelievre, Jean Daniel ^{[24
]}

de Lamballerie, Xavier ^{[15
]}

Kieny, Marie Paule ^{[25
]}

Tartour, Eric ^{[26
]}

Launay, Odile ^{[1
]}

机构：

[1] Univ Paris Cite, Natl Inst Hlth & Med Res INSERM CIC 1417 Cochin P, Innovat Clin Res Network Vaccinol I REIVAC, Hop Cochin,Assistance Publ Hop Paris AP HP, Paris, France

[2] INSERM SC10 US019, Villejuif, France

[3] Hop Univ Pitie Salpetriere, AP HP, Hop Univ Pitie Salpetriere Charles Foix, Unite Rech Clin, Paris, France

[4] Hop Cochin, AP HP, Federat Ctr Ressources Biol Plateforme Ressources, Ctr Ressources Biol Cochin, Paris, France

[5] Univ Bordeaux, Ctr Hosp Univ CHU Bordeaux, Lab Immunol & Immunogenet,INSERM ERL 1303,ImmunoC, Ctr Natl Rech Sci CNRS,Unite Mixte Rech UMR 5164, Bordeaux, France

[6] Hop Cochin, AP HP, Serv Immunol Biol & Plateforme Immunomonitoring V, Paris, France

[7] PSL Res Univ INSERM U900 MINES ParisTech, Inst Curie, PSL, Paris, France

[8] French Blood Ctr EFS Bretagne, Lab Immunol Res Unit INSERM U 1236, B Cell Ig Remodelling Singular BIGRES, Fac Med, Rennes, France

[9] Univ Hosp, Rennes, France

[10] Sorbonne Univ, INSERM U1135, Ctr Immunol & Malad Infect Paris Cimi Paris, Paris, France

[11] Univ Geneva, Fac Med, Div Gen Pediat, Dept Woman Child & Adolescent Med, Geneva, Switzerland

[12] Univ Geneva, Ctr Vaccinol, Geneva, Switzerland

[13] Sorbonne Univ, Hop Pitie Salpetriere, AP HP, INSERM,Ctr Immunol & Malad Infect CIMI Paris,Dept, Paris, France

[14] CNRS, UMR 144, Paris, France

[15] Aix Marseille Univ, Res Inst Sustainable Dev IRD 190, INSERM 1207, IHU Mediterranee Infect,Unite Virus Emergents, Marseille, France

[16] UJM, INSERM, U1111,CIRI GIMAP,UCBL 1,CIC 1408, CNRS,UMR 530,Immunol & Immunomonitoring Lab,iBiot, St Etienne, France

[17] Univ Paris Cite, Unite Genet Mol Virus ARN UMR 3569 CNRS, Inst Pasteur, Paris, France

[18] CHU Nantes, Ctr Prevent Malad Infect & Transmissibles, INSERM CIC1413, Malad Infect & Trop, Nantes, France

[19] CHU St Etienne, Serv Infectiol, INSERM CIC 1408, Axe Vaccinol, St Etienne, France

[20] ANRS Emerging Infect Dis, Paris, France

[21] Alliance Int Med Act ALIMA, Paris, France

[22] Univ Bordeaux, INSERM, IRD, Bordeaux Populat Hlth Ctr,UMR 1219, Bordeaux, France

[23] Ctr Vaccine Dev, Bamako, Mali

[24] INSERM U955, Vaccine Res Inst, Creteil, France

[25] INSERM 101, Paris, France

[26] Hop Europeen Georges Pompidou, AP HP, INSERM U970, PARCC, Paris, France

来源：

NATURE MEDICINE | 2022年 / 28卷 / 05期

关键词：

D O I：

10.1038/s41591-022-01785-4

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

引用

页码：882 / 884

页数：3

共 50 条

[1] A comparison of Sars-Cov-2 vaccine platforms: the CoviCompare project
Diana Molino
Christine Durier
Anne Radenne
Corinne Desaint
Jacques Ropers
Soizic Courcier
Louis Victorien Vieillard
Claire Rekacewicz
Beatrice Parfait
Victor Appay
Frédéric Batteux
Emmanuel Barillot
Michel Cogné
Béhazine Combadière
Christiane S. Eberhardt
Guy Gorochov
Philippe Hupé
Laetitia Ninove
Stéphane Paul
Isabelle Pellegrin
Sylvie van der Werf
Maeva Lefebvre
Elisabeth Botelho-Nevers
Inmaculada Ortega-Perez
Marie Jaspard
Samba Sow
Jean Daniel Lelièvre
Xavier de Lamballerie
Marie Paule Kieny
Eric Tartour
Odile Launay
[J]. Nature Medicine, 2022, 28 : 882 - 884
[2] Platforms Exploited for SARS-CoV-2 Vaccine Development
Mathew, Shilu
Faheem, Muhammed
Hassain, Neeraja A.
Benslimane, Fatiha M.
Al Thani, Asmaa A.
Zaraket, Hassan
Yassine, Hadi M.
[J]. VACCINES, 2021, 9 (01) : 1 - 24
[3] Adenoviral vector vaccine platforms in the SARS-CoV-2 pandemic
Samir Andrade Mendonça
Reka Lorincz
Paul Boucher
David T. Curiel
[J]. npj Vaccines, 6
[4] Adenoviral vector vaccine platforms in the SARS-CoV-2 pandemic
Mendonca, Samir Andrade
Lorincz, Reka
Boucher, Paul
Curiel, David T.
[J]. NPJ VACCINES, 2021, 6 (01)
[5] New vaccine production platforms used in developing SARS-CoV-2 vaccine candidates
Ura, Takehiro
Yamashita, Akio
Mizuki, Nobuhisa
Okuda, Kenji
Shimada, Masaru
[J]. VACCINE, 2021, 39 (02) : 197 - 201
[6] mRNA technology as one of the promising platforms for the SARS-CoV-2 vaccine development
Ilyichev, A. A.
Orlova, L. A.
Sharabrin, S., V
Karpenko, L., I
[J]. VAVILOVSKII ZHURNAL GENETIKI I SELEKTSII, 2020, 24 (07): : 802 - 807
[7] Diverse vaccine platforms safeguarding against SARS-CoV-2 and its variants
Chatterjee, Bhaswati
Thakur, Suman S.
[J]. EXPERT REVIEW OF VACCINES, 2022, 21 (01) : 47 - 67
[8] SARS-CoV-2 mucosal vaccine
Houston, Stephanie
[J]. NATURE IMMUNOLOGY, 2023, 24 (01) : 1 - 1
[9] A VACCINE AGAINST SARS-COV-2
Passi, Gouri Rao
[J]. INDIAN PEDIATRICS, 2020, 57 (06) : 593 - 593
[10] Inactivated vaccine for SARS-CoV-2
Emma Risson
[J]. Nature Reviews Immunology, 2020, 20 : 353 - 353

← 1 2 3 4 5 →